(Q35079183)

English

A randomised double-blind placebo-controlled 12- week feasibility trial of methotrexate added to treatment as usual in early schizophrenia: study protocol for a randomised controlled trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

6 August 2017

A randomised double-blind placebo-controlled 12- week feasibility trial of methotrexate added to treatment as usual in early schizophrenia: study protocol for a randomised controlled trial (English)

1 reference

Europe PubMed Central

6 August 2017

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

9

object named as

Maya H Buch

1 reference

Europe PubMed Central

6 August 2017

object named as

Nusrat Husain

2

0 references

object named as

Bill Deakin

15

0 references

author name string

Imran B Chaudhry

1

1 reference

Europe PubMed Central

6 August 2017

Raza ur Rahman

3

1 reference

Europe PubMed Central

6 August 2017

Mohammed Omair Husain

4

1 reference

Europe PubMed Central

6 August 2017

Mohammed M Hamirani

5

1 reference

Europe PubMed Central

6 August 2017

Ajmal Kazmi

6

1 reference

Europe PubMed Central

6 August 2017

Shakeel Baig

7

1 reference

Europe PubMed Central

6 August 2017

Peter M Haddad

8

1 reference

Europe PubMed Central

6 August 2017

Inti Qureshi

10

1 reference

Europe PubMed Central

6 August 2017

Nasir Mehmood

11

1 reference

Europe PubMed Central

6 August 2017

Tayyeba Kiran

12

1 reference

Europe PubMed Central

6 August 2017

Bo Fu

13

1 reference

Europe PubMed Central

6 August 2017

Salahuddin Afsar

14

1 reference

Europe PubMed Central

6 August 2017

publication date

7 January 2015

1 reference

Europe PubMed Central

6 August 2017

1 reference

Europe PubMed Central

6 August 2017

16

1 reference

Europe PubMed Central

6 August 2017

9

1 reference

Europe PubMed Central

6 August 2017

https://scigraph.springernature.com/pub.10.1186/1745-6215-16-9

0 references

Cytokines in schizophrenia: possible role of anti-inflammatory medications in clinical and preclinical stages

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4326487

8 July 2018

Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4326487

8 July 2018

Kynurenines: from the perspective of major psychiatric disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4326487

8 July 2018

Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4326487

8 July 2018

Effects of methotrexate on plasma cytokines and cardiac remodeling and function in postmyocarditis rats.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4326487

8 July 2018

Neuroinflammation in schizophrenia-related psychosis: a PET study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4326487

8 July 2018

Glial cells in schizophrenia: pathophysiological significance and possible consequences for therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4326487

8 July 2018

Cytokines and schizophrenia: Microglia hypothesis of schizophrenia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4326487

8 July 2018

Interleukin-6 mediates the increase in NADPH-oxidase in the ketamine model of schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4326487

8 July 2018

Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4326487

8 July 2018

Cytokines in schizophrenia and the effects of antipsychotic drugs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4326487

8 July 2018

Low-dose methotrexate: a mainstay in the treatment of rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4326487

8 July 2018

Folate supplementation and methotrexate treatment in rheumatoid arthritis: a review.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4326487

8 July 2018

Interaction of dihydrofolate reductase with methotrexate: ensemble and single-molecule kinetics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4326487

8 July 2018

The efficacy of folic acid and folinic acid in reducing methotrexate gastrointestinal toxicity in rheumatoid arthritis. A metaanalysis of randomized controlled trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4326487

8 July 2018

The positive and negative syndrome scale (PANSS) for schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4326487

8 July 2018

Enhancement of Recovery from Psychiatric Illness by Methylfolate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4326487

8 July 2018

Different distribution patterns of lymphocytes and microglia in the hippocampus of patients with residual versus paranoid schizophrenia: further evidence for disease course-related immune alterations?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4326487

27 September 2018

Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4326487

27 September 2018

Tumor necrosis factor-alpha and interleukin-6 regulate secretion of brain-derived neurotrophic factor in human monocytes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4326487

27 September 2018

The anti-inflammatory action of methotrexate is not mediated by lymphocyte apoptosis, but by the suppression of activation and adhesion molecules

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4326487

27 September 2018

The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/25563714

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Social Functioning Scale. The development and validation of a new scale of social adjustment for use in family intervention programmes with schizophrenic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/25563714

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. A double-blind, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/25563714

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The nonspecific anti-inflammatory therapy with methotrexate for patients with chronic heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/25563714

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1745-6215-16-9

1 reference

Europe PubMed Central

6 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

6 August 2017

1 reference

Europe PubMed Central

6 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35079183&oldid=1978027917"